Previous studies have primarily focused on the relationship between ELANE gene mutations and severe congenital neutropenia (SCN) as well as their progression to myelodysplastic syndromes/acute myeloid leukemia (MDS/AML) [34,35]. This evidence concerns the gene ELANE and severe congenital neutropenia.